In the News ...   LS9 Purchases Florida Site to Manufacture Renewable Petroleum Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel® BG Medicine Files Registration Statement for Proposed Initial Public Offering VisEn Acquires Key Fluorescence Agent Intellectual Property Portfolio and Technology Platforms from Bayer Schering Pharma BG Medicine Announces Receipt of CE Mark for its Galectin-3 Blood Test 01/27/2010 LS9, Inc., U.C Berkeley, and JBEI Make Major Breakthrough in Cellulosic Fuels Production Joule Biotechnologies Secures Pilot Site for Renewable Solar Fuel Helicos BioSciences Announces the Sale of a Helicos® Genetic Analysis System to the Turku BIND Biosciences, Inc. Closes $11M Series C Financing Round BIND Biosciences Appoints Scott Minick as President and CEO
Flagship Ventures | One Memorial Drive, 7th Floor | Cambridge, MA 02142 | 617.868.1888
© 2009 Flagship Ventures. All rights reserved.